609 Results

People

  1. Lilja
    Lilja
  2. Vickers
    Vickers
  3. Scher
    Scher
  4. Eastham
    Eastham
  5. Scardino
    Scardino
  6. Zelefsky
    Zelefsky
  7. Kattan
    Kattan
  8. Carlsson
    Carlsson
  9. Kelly
    Kelly
  10. Slovin
    Slovin

Groups

  1. Surgery (295)
  2. Urology (293)
  3. Population Sciences Research Program (215)
  4. Epidemiology and Biostatistics (178)
  5. Sloan Kettering Institute Faculty (171)
  6. Molecular Pharmacology and Chemistry Program Faculty (168)
  7. Department of Medicine (143)
  8. Solid Tumor Oncology Division (138)
  9. Genitourinary Oncology Service (135)
  10. Health Outcomes Research Group (133)
  1. "prostate-specific antigen"
Formats
  1. Journal Article (570)
  2. Editorial (8)
  3. Review (8)
  4. Conference Paper (6)
  5. Guidelines (5)
  6. Meeting Abstract (4)
  7. Book Section (3)
  8. Correspondence (3)
  9. Research Letter (2)
Groups
  1. Surgery (295)
  2. Urology (293)
  3. Population Sciences Research Program (215)
  4. Epidemiology and Biostatistics (178)
  5. Sloan Kettering Institute Faculty (171)
  6. Molecular Pharmacology and Chemistry Program Faculty (168)

More Groups

People
  1. Hans Lilja (135)
  2. Peter Scardino (117)
  3. Andrew Vickers (98)
  4. Howard Scher (96)
  5. James Eastham (80)
  6. Michael Zelefsky (64)

More People

Years
  1. 2025 (3)
  2. 2024 (26)
  3. 2023 (28)
  4. 2022 (28)
  5. 2021 (8)
  6. 2020 (5)

More Years

Publications
  1. Journal of Urology (69)
  2. European Urology (47)
  3. International Journal of Radiation Oncology, Biology, Physics (40)
  4. Journal of Clinical Oncology (39)
  5. Urology (36)
  6. Clinical Cancer Research (31)

More Publications

Publishers
  1. Elsevier Science, Inc. (162)
  2. Elsevier Inc. (72)
  3. Wiley Blackwell (64)
  4. American Association for Cancer Research (46)
  5. American Society of Clinical Oncology (39)
  6. John Wiley & Sons (29)

More Publishers

Results (609)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and gleason grade
    Journal Article

    Haese, A.; Vaisanen, V.; Lilja, H.; Kattan, M. W.; Rittenhouse, H. G.; Pettersson, K.; Chan, D. W.; Huland, H.; Sokoll, L. J.; Partin, A. W.
    Journal of Urology (2005)

    Fulltext@MSK | Save
  • Prostate-specific antigen doubling time as a prognostic marker in prostate cancer
    Journal Article

    Eastham, J. A.
    Nature Clinical Practice Urology (2005)

    Fulltext@MSK | Save
  • Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy
    Journal Article

    Dotan, Z. A.; Bianco, F. J. Jr; Rabbani, F.; Eastham, J. A.; Fearn, P.; Scher, H. I.; Kelly, K. W.; Chen, H. N.; Schoder, H.; Hricak, H.; more...
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Gleason grade remains an important prognostic predictor in men diagnosed with prostate cancer while on finasteride therapy
    Journal Article

    Carver, B. S.; Kattan, M. W.; Scardino, P. T.; Eastham, J. A.
    BJU International (2005)

    Fulltext@MSK | Save
  • Assessment of intra-individual variation in prostate-specific antigen levels in a biennial randomized prostate cancer screening program in Sweden
    Journal Article

    Bruun, L.; Becker, C.; Hugosson, J.; Lilja, H.; Christensson, A.
    Prostate (2005)

    Fulltext@MSK | Save
  • Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?
    Journal Article

    Boorjian, S. A.; Bianco, F. J. Jr; Scardino, P. T.; Eastham, J. A.
    BJU International (2005)

    Fulltext@MSK | Save
  • Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy
    Journal Article

    Bianco, F. J. Jr; Scardino, P. T.; Stephenson, A. J.; Di Blasio, C. J.; Fearn, P. A.; Eastham, J. A.
    International Journal of Radiation Oncology, Biology, Physics (2005)

    Fulltext@MSK | Save
  • Androgen deprivation for minimal metastatic disease: Threshold for achieving undetectable prostate-specific antigen
    Journal Article

    Beekman, K.; Morris, M.; Slovin, S.; Heller, G.; Wilton, A.; Bianco, F.; Scardino, P. T.; Scher, H. I.
    Urology (2005)

    Fulltext@MSK | Save
  • Individualized screening interval for prostate cancer based on prostate-specific antigen level: Results of a prospective, randomized, population-based study
    Journal Article

    Aus, G.; Damber, J. E.; Khatami, A.; Lilja, H.; Stranne, J.; Hugosson, J.
    Archives of Internal Medicine (2005)

    Fulltext@MSK | Save
  • The risk of finding focal cancer (less than 3 mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionable
    Journal Article

    Zackrisson, B.; Aus, G.; Bergdahl, S.; Lilja, H.; Lodding, P.; Pihl, C. G.; Hugosson, J.
    Journal of Urology (2004)

    Fulltext@MSK | Save